US-based IMS Health has acquired UK-based Dataline Software, a provider of big data analytics for healthcare industry.

The acquisition will allow IMS Health to expand its technology-enabled real-world evidence (RWE) platform, in addition to accelerating delivery of integrated clinical and cost-of-care insights to evaluate healthcare value and performance.

Dataline’s software tools will enhance the capabilities of Evidence 360, IMS Health’s scalable and secure RWE platform that allows clients to extract, analyze and visualize real-world data to better understand and measure healthcare outcomes.

IMS Health real-world evidence solutions general manager and vice-president Jon Resnick said: "Life sciences companies continue to invest in RWE to better leverage the growing volume of rich, complex healthcare information that is becoming available."

The Evidence 360 platform features enhanced search engine that supports secure access to data and will integrate Dataline’s patented algorithm designed for searching complex EMR datasets.

It also features improved R&D, clinical trial and observational studies capabilities and enhanced visualization tools to increase usability of insights.